Form 8-K - Current report:
SEC Accession No. 0001628280-19-010032
Filing Date
2019-08-06
Accepted
2019-08-06 08:10:10
Documents
17
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 6.30.19 EARNINGS RELEASE earningsrelease8-k6x30.htm   iXBRL 8-K 57926
2 EXHIBIT 99.1 exhibit991q22019earnin.htm EX-99.1 197744
8 vericellogoa18.jpg GRAPHIC 48734
  Complete submission text file 0001628280-19-010032.txt   486900

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT astm-20190630.xsd EX-101.SCH 5190
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT astm-20190630_cal.xml EX-101.CAL 867
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT astm-20190630_def.xml EX-101.DEF 1716
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT astm-20190630_lab.xml EX-101.LAB 26457
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT astm-20190630_pre.xml EX-101.PRE 14102
9 EXTRACTED XBRL INSTANCE DOCUMENT earningsrelease8-k6x30_htm.xml XML 4264
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 191000488
SIC: 2836 Biological Products, (No Diagnostic Substances)